Search results
BioRestorative Therapies maintains its 'Buy' rating and $15 target price By Investing.com
Investing.com· 24 hours agoThe firm highlighted the company's solid financial standing, with $16.4 million in cash reserves at...
RA Disease Activity Impacts Severity of Associated ILD
Medscape· 14 hours agoRheumatoid arthritis disease activity influenced the severity of interstitial lung disease, an associated comorbidity, thereby affecting patients' prognosis, showed study.
CollPlant prints commercial-size regenerative breast implants By Investing.com
Investing.com· 6 days agoCollPlant Biotechnologies (NASDAQ:CLGN), an innovator in regenerative and aesthetic medicine, has...
Calico Life Sciences Announces that Fosigotifator (ABBV-CLS-7262) for Vanishing White Matter Disease...
KNDO - KNDU Tri-Cities· 6 days agoFosigotifator is being developed by Calico and AbbVie pursuant to their 2014 collaboration as a potential treatment for Vanishing White Matter (VWM) disease. FDA's Center ...
More Tender Than Swollen Joints Worsen Outcomes in Early RA
Medscape· 7 days agoPatients with early rheumatoid arthritis who had higher tender-swollen joint differences showed...
Once-Weekly Somapacitan Remains Safe, Effective Long-Term
Medscape· 7 days agoGrowth improvements were similar between children taking somapacitan for 3 years and those who...
Moderna's MMA candidate nabs spot in FDA pilot for rare disease drugs
FierceBiotech· 6 days agoModerna’s methylmalonic acidemia candidate, mRNA-3705, will be developed under the FDA’s START pilot...
Seladelpar Shows Clinically Meaningful Improvements in PBC
Medscape· 3 days agoThe first analysis of 337 patients with PBC, with and without cirrhosis, showed that treatment with seladelpar had a durable effect up to 2 years on cholestasis and markers of liver injury, ...
EULAR 2024 Preview: What's Not to Miss?
Medscape· 4 days agoEULAR 2024 Preview: What's Not to Miss at This Year's Congress? The European Alliance of Associations for Rheumatology (EULAR) 2024 European Congress of...
These Biotech Stocks Hit New Highs, Did You Reap The Rewards?
RTT News· 6 days agoProtagonist is a clinical-stage biopharmaceutical company with multiple assets having billion-dollar market potential. The company has a worldwide license and collaboration agreement with Takeda ...